{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"}],"units":"Participants"}],"groups":[{"description":"Conditioning with Treosulfan (12 or 14 g/m2, IV for 5 days) and Fludarabine (30 mg/m2, IV for 5 days) followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies","id":"OG000","title":"Treosulfan and Fludarabine Conditioning"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"One year","title":"Number of Subjects Who Are Without Disease at One Year as Indicator of Disease Free Survival.","type":"SECONDARY","unitOfMeasure":"participants"}